FAETH THERAPEUTICS INC FTH
COM NEW · Common Stock · CUSIP 81728A207
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersAustin, TX
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 1.3m as of 2025-07-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $8.58.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2025 | 1 |
| Q2 2025 | 11 |
Biggest buyers
| VANGUARD GROUP INC | New | +29.1k |
| Ikarian Capital, LLC | New | +22.5k |
| Catalio Capital Management, LP | New | +14.7k |
| UBS Group AG | New | +2.1k |
| RAYMOND JAMES FINANCIAL INC | New | +700 |
| BANK OF AMERICA CORP /DE/ | New | +583 |
| SBI Securities Co., Ltd. | New | +149 |
| JPMORGAN CHASE & CO | New | +32 |
| MORGAN STANLEY | New | +10 |
| BNP PARIBAS FINANCIAL MARKETS | New | +9 |
Biggest sellers
| NWF Advisory Services Inc. | Sold out | -16.5k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Khosla Ventures VI, L.P. 13G · exempt (held before listing) new · filed 2026-08-14 | 10.2% |
| S2G Investments, LLC 13G · passive investor new · filed 2026-06-23 | 10.0% |
| SUVRETTA CAPITAL MANAGEMENT, LLC 13G · passive investor new · filed 2026-06-23 | 7.8% |
Fell to 5% or below in the last year: Caligan Partners LP (2.4%, 2026-08-14), STEMPOINT CAPITAL LP (0.0%, 2026-08-14), Trails Edge Capital Partners, LP (2.0%, 2026-08-14), MILLENNIUM MANAGEMENT LLC (3.1%, 2026-06-03)
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2023 | 1 | $425 | 0 | — | — |
| Q4 2023 | 0 | — | 0 | — | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 0 | — | 0 | — | — |
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
None reported in Q2 2025.
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| VANGUARD GROUP INC 0.00% of their portfolio | 29.1k $249.6k | New |
| Ikarian Capital, LLC 0.06% of their portfolio | 22.5k $193.0k | New |
| Catalio Capital Management, LP 0.03% of their portfolio | 14.7k $126.3k | New |
| UBS Group AG 0.00% of their portfolio | 2.1k $18.4k | New |
| RAYMOND JAMES FINANCIAL INC 0.00% of their portfolio | 700 $6.0k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 583 $5.0k | New |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 149 $1.3k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 32 $275 | New |
| MORGAN STANLEY 0.00% of their portfolio | 10 $86 | New |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 9 $77 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | New |